Skip to main content

Table 3 Adherence to AMI evidence-based treatment in the follow-up of 3449 patients

From: Is depression a real risk factor for acute myocardial infarction mortality? A retrospective cohort study

EBT class Antidepressant use Total (n. 3449)
Yes (n. 281) No (n. 3168)
n (%) n (%) n (%)
Aspirin/Clopidogrel 242 (86.1) 2879 (90.9) 3121 (90.5)
Beta-blockers 185 (65.8) 2308 (72.9) 2493 (72.3)
Statins 176 (62.6) 2293 (72.4) 2469 (71.6)
ACEIs/ARBs 184 (65.5) 2344 (74.0) 2528 (73.3)
Combination EBT 121 (43.1) 1630 (51.5) 1751 (50.8)
  1. EBT evidence-based treatment, ACEIs angiotensin-converting enzyme inhibitors, ARBs angiotensin receptor blockers